Zen-Bio, Inc.
Stem cell-derived exosomes for chronic wound healing
- Sector
- Biotech
- Headquarters
- Research Triangle Park, NC
- Total capital
- $8.9M
- Federal grants
- $7.8M
- 11 awards · 2015–2020
- Rank in peer group#77 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.1M
- 13 awards · Veterans Affairs, Health and Human S, Defense
- Rank in Biotech#183 of 4373
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal contractDefense · Human Blood For Research Utilizing Malaria Parasite Cultures$49K
- Federal contractHealth and Human S · Blood$88K
- Federal contractHealth and Human S · 24-012705 Nhlbi, Mchb Requires Cord Blood CD34+/CD133+ Cells In Order To Use For Cell Culture Experiment To Develop Novel Gene Therapy Strategies.$19K
- Federal contractHealth and Human S · Zen-bio Funding Base Bpa Order$33K
- Federal contractHealth and Human S · Zen-bio Funding Base Bpa Order$100K
- Federal contractDefense · Screened Human Serum - A+$179K
- Federal grantHealth and Human S · Phase II · Tuned stem cell extracellular vesicles are a novel chronic wound therapeutic$1.2M
Show 17 earlier federal awards
- Federal grantHealth and Human S · Phase II · Tuned stem cell extracellular vesicles are a novel chronic wound therapeutic$2M
- Federal contractDefense · Human Serum, A+$51K
- Federal grantHealth and Human S · Phase I · A Novel Human Primary Meibomian Gland Cell Platform for Dry Eye Therapeutics$217K
- Federal grantHealth and Human S · Phase I · Selective Tuning of Stem Cell Extracellular Vesicles as a Novel Therapy for Age-related Tendinopathy$222K
- Federal grantHealth and Human S · Phase I · Tuned stem cell extracellular vesicles as a novel chronic wound therapeutic$223K
- Federal grantHealth and Human S · Phase II · Development and validation of a human brown adipocyte system$722K
- Federal grantHealth and Human S · Phase II · Development and validation of a human brown adipocyte system$1.5M
- Federal grantHealth and Human S · Phase I · A novel class of anti-acne therapeutics$225K
- Federal contractHealth and Human S · Igf::ot::igf High Content Screening For Human Primary Pancreatic Cell Type-specific Toxicants$225K
- Federal grantHealth and Human S · Phase II · Selective Fyn kinase inhibitors for treatment of metabolic disease$643K
- Federal grantHealth and Human S · Phase II · Development of a drug discovery platform for human islets$682K
- Federal grantHealth and Human S · Phase I · Development and validation of a human brown adipocyte system$224K
- Federal contractHealth and Human S · Igf::ot::igf For Other Functions - Creating An Als Pilot Fibroblast Bank$288K
- Federal contractHealth and Human S · Dna Isolation/quantification With Post Sort Flow Cytometry$25K
- Federal contractVeterans Affairs · Small Purchase Data$2K
- Federal contractVeterans Affairs · Small Purchase Data$350
- Federal contractVeterans Affairs · Human Omental Tissue Rna From Diabetic Patient, 10$2K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#77 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 2- PendingExosome Compositions And Methods For Preparation And Use ThereofUSPTOApplication 62199696
- PendingHuman Omental Mesothelial Cells, Methods Of Isolation And Uses ThereofUSPTOApplication PCTUS2010054957
Related companies, and why
- ORBIS BIOSCIENCES, INC.Similar federal contract value in Biotech · $1.1M in contracts
- PARABON COMPUTATION, INC.Similar federal contract value in Biotech · $1.1M in contracts
- ANTIRADICAL THERAPEUTICS LLCSimilar federal contract value in Biotech · $1.1M in contracts
- SunFire Biotechnologies LLCSimilar federal contract value in Biotech · $1.1M in contracts
- Molecular Loop Biosciences, Inc.Similar federal contract value in Biotech · $1M in contracts
- OXFORD BIOMEDICAL RESEARCH, INC.Similar federal contract value in Biotech · $1M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .